vs

Side-by-side financial comparison of AUDIOEYE INC (AEYE) and ASSEMBLY BIOSCIENCES, INC. (ASMB). Click either name above to swap in a different company.

ASSEMBLY BIOSCIENCES, INC. is the larger business by last-quarter revenue ($10.8M vs $10.5M, roughly 1.0× AUDIOEYE INC). AUDIOEYE INC runs the higher net margin — -10.0% vs -85.2%, a 75.2% gap on every dollar of revenue. On growth, ASSEMBLY BIOSCIENCES, INC. posted the faster year-over-year revenue change (57.6% vs 7.9%). AUDIOEYE INC produced more free cash flow last quarter ($2.5M vs $-15.2M).

AudioEye Inc. is a digital accessibility technology provider that delivers automated and manual solutions to help organizations make their websites, mobile applications, and other digital assets accessible to users with disabilities. It serves clients across retail, education, healthcare, government and other sectors primarily in the North American market, supporting compliance with global accessibility standards.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

AEYE vs ASMB — Head-to-Head

Bigger by revenue
ASMB
ASMB
1.0× larger
ASMB
$10.8M
$10.5M
AEYE
Growing faster (revenue YoY)
ASMB
ASMB
+49.7% gap
ASMB
57.6%
7.9%
AEYE
Higher net margin
AEYE
AEYE
75.2% more per $
AEYE
-10.0%
-85.2%
ASMB
More free cash flow
AEYE
AEYE
$17.7M more FCF
AEYE
$2.5M
$-15.2M
ASMB

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
AEYE
AEYE
ASMB
ASMB
Revenue
$10.5M
$10.8M
Net Profit
$-1.1M
$-9.2M
Gross Margin
78.9%
Operating Margin
-7.8%
-100.9%
Net Margin
-10.0%
-85.2%
Revenue YoY
7.9%
57.6%
Net Profit YoY
29.3%
4.3%
EPS (diluted)
$-0.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AEYE
AEYE
ASMB
ASMB
Q4 25
$10.5M
Q3 25
$10.2M
$10.8M
Q2 25
$9.9M
$9.6M
Q1 25
$9.7M
$9.4M
Q4 24
$9.7M
$7.4M
Q3 24
$8.9M
$6.8M
Q2 24
$8.5M
$8.5M
Q1 24
$8.1M
$5.8M
Net Profit
AEYE
AEYE
ASMB
ASMB
Q4 25
$-1.1M
Q3 25
$-554.0K
$-9.2M
Q2 25
$-2.0K
$-10.2M
Q1 25
$-1.5M
$-8.8M
Q4 24
$-1.5M
Q3 24
$-1.2M
$-9.6M
Q2 24
$-735.0K
$-11.2M
Q1 24
$-829.0K
$-9.1M
Gross Margin
AEYE
AEYE
ASMB
ASMB
Q4 25
78.9%
Q3 25
77.4%
Q2 25
77.3%
Q1 25
79.5%
Q4 24
80.3%
Q3 24
79.6%
Q2 24
79.2%
Q1 24
78.2%
Operating Margin
AEYE
AEYE
ASMB
ASMB
Q4 25
-7.8%
Q3 25
-3.1%
-100.9%
Q2 25
2.5%
-115.2%
Q1 25
-9.7%
-105.5%
Q4 24
-13.1%
Q3 24
-11.1%
-160.1%
Q2 24
-5.9%
-143.0%
Q1 24
-7.8%
-185.5%
Net Margin
AEYE
AEYE
ASMB
ASMB
Q4 25
-10.0%
Q3 25
-5.4%
-85.2%
Q2 25
-0.0%
-105.9%
Q1 25
-15.1%
-93.6%
Q4 24
-15.3%
Q3 24
-13.5%
-140.4%
Q2 24
-8.7%
-130.7%
Q1 24
-10.3%
-156.9%
EPS (diluted)
AEYE
AEYE
ASMB
ASMB
Q4 25
Q3 25
$-0.04
$-0.72
Q2 25
$-1.33
Q1 25
$-1.17
Q4 24
$-0.13
Q3 24
$-0.10
$-1.51
Q2 24
$-0.06
$-1.98
Q1 24
$-0.07
$-1.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AEYE
AEYE
ASMB
ASMB
Cash + ST InvestmentsLiquidity on hand
$5.3M
$22.5M
Total DebtLower is stronger
$13.4M
Stockholders' EquityBook value
$4.8M
$182.7M
Total Assets
$32.2M
$240.0M
Debt / EquityLower = less leverage
2.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AEYE
AEYE
ASMB
ASMB
Q4 25
$5.3M
Q3 25
$4.5M
$22.5M
Q2 25
$6.9M
$24.0M
Q1 25
$8.3M
$23.4M
Q4 24
$5.7M
$38.3M
Q3 24
$5.5M
$28.5M
Q2 24
$5.1M
$19.2M
Q1 24
$7.0M
$18.7M
Total Debt
AEYE
AEYE
ASMB
ASMB
Q4 25
$13.4M
Q3 25
$13.4M
Q2 25
$13.4M
Q1 25
$12.0M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AEYE
AEYE
ASMB
ASMB
Q4 25
$4.8M
Q3 25
$5.7M
$182.7M
Q2 25
$7.3M
$18.1M
Q1 25
$7.9M
$27.1M
Q4 24
$9.4M
$33.4M
Q3 24
$7.4M
$26.0M
Q2 24
$4.9M
$34.7M
Q1 24
$4.9M
$32.6M
Total Assets
AEYE
AEYE
ASMB
ASMB
Q4 25
$32.2M
Q3 25
$30.5M
$240.0M
Q2 25
$33.9M
$80.8M
Q1 25
$33.1M
$99.0M
Q4 24
$29.8M
$119.2M
Q3 24
$29.4M
$100.3M
Q2 24
$22.0M
$115.3M
Q1 24
$23.6M
$119.9M
Debt / Equity
AEYE
AEYE
ASMB
ASMB
Q4 25
2.79×
Q3 25
2.37×
Q2 25
1.82×
Q1 25
1.51×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AEYE
AEYE
ASMB
ASMB
Operating Cash FlowLast quarter
$2.5M
$-15.1M
Free Cash FlowOCF − Capex
$2.5M
$-15.2M
FCF MarginFCF / Revenue
23.9%
-140.7%
Capex IntensityCapex / Revenue
0.3%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AEYE
AEYE
ASMB
ASMB
Q4 25
$2.5M
Q3 25
$1.0M
$-15.1M
Q2 25
$1.2M
$-16.8M
Q1 25
$-44.0K
$-23.4M
Q4 24
$565.0K
$-51.1M
Q3 24
$1.6M
$-15.2M
Q2 24
$410.0K
$-17.1M
Q1 24
$203.0K
$-18.4M
Free Cash Flow
AEYE
AEYE
ASMB
ASMB
Q4 25
$2.5M
Q3 25
$1.0M
$-15.2M
Q2 25
$1.2M
Q1 25
$-47.0K
Q4 24
$525.0K
$-51.1M
Q3 24
$1.5M
Q2 24
$392.0K
$-17.1M
Q1 24
$146.0K
$-18.4M
FCF Margin
AEYE
AEYE
ASMB
ASMB
Q4 25
23.9%
Q3 25
10.2%
-140.7%
Q2 25
12.1%
Q1 25
-0.5%
Q4 24
5.4%
-695.2%
Q3 24
17.3%
Q2 24
4.6%
-200.6%
Q1 24
1.8%
-317.7%
Capex Intensity
AEYE
AEYE
ASMB
ASMB
Q4 25
0.3%
Q3 25
0.0%
0.4%
Q2 25
0.2%
0.0%
Q1 25
0.0%
0.0%
Q4 24
0.4%
0.4%
Q3 24
0.1%
0.0%
Q2 24
0.2%
0.2%
Q1 24
0.7%
0.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AEYE
AEYE

Partner And Marketplace$5.7M55%
Enterprise$4.8M45%

ASMB
ASMB

Segment breakdown not available.

Related Comparisons